Cochrane Abstracts
Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Metastatic and Recurrent Cervical Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Stapled_versus_handsewn_methods_for_ileocolic_anastomoses:_Cochrane_systematic_review. Accessed 30 November 2023.
Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Stapled_versus_handsewn_methods_for_ileocolic_anastomoses:_Cochrane_systematic_review. Accessed November 30, 2023.
Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Stapled_versus_handsewn_methods_for_ileocolic_anastomoses:_Cochrane_systematic_review
Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Metastatic and Recurrent Cervical Cancer [Internet]. In: Cochrane Abstracts. [cited 2023 November 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Stapled_versus_handsewn_methods_for_ileocolic_anastomoses:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer
ID - 431950
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Stapled_versus_handsewn_methods_for_ileocolic_anastomoses:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
